What question did this study set out to answer?

To examine emerging druggable mechanisms governing kidney fibrogenesis, evaluate modern translational platforms, and summarize novel therapeutic approaches for chronic kidney disease.

August 14, 2026Clinical Kidney JournalOpen Access

Pharmacological Targeting of Kidney Fibrosis: Druggable Mechanisms, Translational Models, and Emerging Antifibrotic Therapies

View Full Paper

Ask AI

Bookmark

To examine emerging druggable mechanisms governing kidney fibrogenesis, evaluate modern translational platforms, and summarize novel therapeutic approaches for chronic kidney disease.
Synthesized recent literature on molecular pathways driving kidney fibrosis, including metabolic rewiring, immune-stromal crosstalk, mechanotransduction, and epigenetic reprogramming.
Assessed modern translational drug-discovery platforms, including artificial intelligence screening, bioengineered tissues, and patient-derived kidney organoids.
Identified actionable molecular nodes beyond classical transforming growth factor-β signaling that support selective and durable antifibrotic interventions.
Characterized key translational bottlenecks, emphasizing that disease heterogeneity and biomarker deficiencies require a pharmacology-driven framework for patient stratification.

Discussion

No takes yet. Share an insight, caveat, or question.

Implication

Narrative review outlines druggable mechanisms and advanced translational models for kidney fibrosis, highlighting pathways toward precision antifibrotic therapies in chronic kidney disease.

Cite This Study

Chen et al. (2026) studied this question.

synapsesocial.com/papers/6a7ec746b70b84ec8b9136bd https://doi.org/10.1093/ckj/sfag275

View Full Paper

Ask AI

Bookmark

Implication

Narrative review outlines druggable mechanisms and advanced translational models for kidney fibrosis, highlighting pathways toward precision antifibrotic therapies in chronic kidney disease.

Pharmacological Targeting of Kidney Fibrosis: Druggable Mechanisms, Translational Models, and Emerging Antifibrotic Therapies

Key Points

Discussion

Implication

Cite This Study

Pharmacological Targeting of Kidney Fibrosis: Druggable Mechanisms, Translational Models, and Emerging Antifibrotic Therapies

Key Points

Discussion

Implication

Cite This Study

Also Consider

Also Consider